They further demonstrated that the imbalance between histone acetyltransferases (HATs) and HDACs can be corrected by using HDAC inhibitors, which can help regulate transcription, maintain neuronal homeostasis, and provide neuroprotection in disorders such as PD [48]. Here, HDAC9 is linked to Parkinson disease.